GnRH agonists, such as leuprolide, goserelin, and triptorelin, and GnRH antagonists, such as degarelix, are used to treat non‐metastatic PCa patients to lower testosterone by decreasing luteinizing hormone and follicle‐stimulating hormone levels. This evidence concerns the gene GNRH1 and posterior cortical atrophy.